CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer - Japan
doi 10.1007/s12282-018-0888-y
Full Text
Open PDFAbstract
Available in full text
Date
July 3, 2018
Authors
Publisher
Springer Science and Business Media LLC